Login

Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald. 00:10:00

Share On Facebook Share On Twitter

Tommy Logtenberg is the CEO of The Market Herald.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Jefferies is one of the worlds leading fullservice investment banking and capital markets firms|Richard B. Handler,CEO,Jefferies & Company
00:00:00
Noxopharm hails new Sofra™ drug inflammation results - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd
00:10:00
Dan and Sindre Win AF Group's Engineering Student Competition | Amund Tøftum - CEO of AF Group
00:10:00
Addressing Priorities and Seizing Opportunities: Ensuring Energy Security and Financial Sustainability Amidst Change | Rodrigo Costa, CEO , REN - Redes Energéticas Nacionais.
00:10:00
Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta
00:10:00
Why "Bespoke": Custom-Tailored Portfolios with Laurel Hardy | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Senator Chuck Grassley on Congressional Oversight in American Constitutionalism|Chuck Grassley
00:10:00
Exploring Alternative Retirement Planning Strategies
00:10:00
the concept of failure and how it might not be the best way to learn|Daniel Levine,Partner,Accel
00:10:00
Warren Owen Discusses Commodities and Electrification in Mining Sector
00:10:00
William E. Ford on Energy Transition and Global Investments | William E. Ford, CEO,  General Atlantic.
00:10:00
Strategic Growth in European Real Estate: Insights from Rory Buck of Clarion Partners Europe | Managing Partner, Clarion Partners Europe

© 2026 Nehu